Envista to Present at the 44th Annual J.P. Morgan Healthcare Conference

Rhea-AI Summary

Envista (NYSE: NVST) will present at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12, 2026 from 3:45–4:25 pm PST. A live audio webcast will be available in the Investors section of Envista's website and a replay will be posted for 30 days following the presentation.

Key Figures

Conference edition 44th annual J.P. Morgan Healthcare Conference

Presentation date January 12, 2026 Envista conference presentation

Presentation time 3:45–4:25 pm PST Envista session window

Webcast replay window 30 days Replay availability on Envista website

Market Reality Check

$23.62 Last Close

Volume Volume 2,218,169 is in line with 20‑day average 2,239,229 (relative ~0.99x). normal

Technical Price $23.21 is trading above 200‑day MA at $19.48, near 52‑week high $23.33.

Peers on Argus

NVST gained 2.93% while key peers also showed gains (e.g., XRAY +6.18%, WRBY +9.68%, ICUI +5.2%), but the momentum scanner did not flag a sector‑wide move.

Historical Context

Date	Event	Sentiment	Move	Catalyst
Nov 25	Conference participation	Neutral	-0.3%	Announcement of participation in Evercore healthcare conference with webcast access.
Oct 29	Earnings release	Positive	-0.4%	Strong Q3 2025 adjusted growth but GAAP net loss from tax charge.
Oct 29	Sustainability report	Neutral	-0.4%	Release of 2024 sustainability report with ESG progress highlights.
Sep 30	Earnings call schedule	Neutral	-0.1%	Scheduling details for Q3 2025 earnings conference call and webcast.
Jul 31	Earnings release	Positive	+10.3%	Strong Q2 2025 sales, margin expansion, EPS growth, and guidance raise.

Pattern Detected

Recent news reactions mostly aligned with the tone of announcements, with one notable divergence on strong Q3 2025 earnings where shares fell slightly despite positive metrics.

Recent Company History

Over the last six months, Envista has combined steady investor outreach with improving financials. Q2 2025 results showed stronger profitability and a double‑digit price gain, and Q3 2025 earnings highlighted higher sales and adjusted EPS despite a GAAP loss. Sustainability reporting and conference participation on 07/31/2025, 09/30/2025, 10/29/2025, and 11/25/2025 reflected ongoing engagement but saw modest price moves. Today’s J.P. Morgan conference appearance continues this pattern of scheduled investor‑focused events.

Market Pulse Summary

This announcement highlights Envista’s participation in the 44th J.P. Morgan Healthcare Conference, offering a webcasted presentation on January 12, 2026. It continues a series of investor‑facing events following recent earnings and sustainability disclosures. With shares trading near the 52‑week high and above the 200‑day MA, investors may focus on how management’s commentary at the conference reinforces prior guidance, addresses profitability trends, and frames capital allocation and strategic priorities over the coming quarters.

AI-generated analysis. Not financial advice.

BREA, Calif., Jan. 7, 2026 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) ("Envista") today announced that the company will present at the 44^th Annual J.P. Morgan Healthcare Conference. The presentation will take place on Monday, January 12, 2026, from 3:45 – 4:25 pm PST. 

A live audio webcast of the event will be available in the Investors section of the Envista website at https://investors.envistaco.com/. Additionally, a replay of the webcast will be available on the Envista website for 30 days following the presentation.

ABOUT ENVISTA HOLDINGS CORPORATION

Envista is a global leader in the dental industry, uniting more than 30 trusted brands—including DEXIS, Kerr, Nobel Biocare, and Ormco—under one mission: partnering with dental professionals to improve patients' lives. With a heritage of category-defining innovation, our brands have shaped modern dentistry: Nobel Biocare introduced the first dental implant, Ormco is a pioneer in both traditional and digital orthodontics, DEXIS has long been at the forefront of 2D, 3D and intraoral imaging, and Kerr has supported clinicians for over 135 years. Our high-performing culture is underpinned by our CIRCLe Values and the Envista Business System. Guided by these, we deliver a comprehensive portfolio of technologies, consumables, and services that empower clinicians to provide confident, efficient care—today and for the future. Learn more at http://envistaco.com. 

FOR FURTHER INFORMATION

Jim Gustafson
Vice President, Investor Relations
Envista Holdings Corporation
200 S. Kraemer Blvd., Building E
Brea, CA 92821
Telephone: (714) 817-7000
ir@envistaco.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/envista-to-present-at-the-44th-annual-jp-morgan-healthcare-conference-302655645.html

SOURCE Envista Holdings Corporation

FAQ

When will Envista (NVST) present at the 44th Annual J.P. Morgan Healthcare Conference?

Envista will present on Monday, January 12, 2026 from 3:45–4:25 pm PST.

Where can investors listen to the Envista (NVST) live webcast for the J.P. Morgan presentation?

A live audio webcast will be available in the Investors section of the Envista website at the company's investor site.

How long will the Envista (NVST) webcast replay be available after the presentation?

A replay of the webcast will be available on the Envista website for 30 days following the presentation.

Is the Envista (NVST) presentation at J.P. Morgan a video or audio webcast?

The company announced a live audio webcast of the presentation.

Will the Envista (NVST) J.P. Morgan presentation include investor materials on the website?

The announcement specifies a live audio webcast and a 30-day replay hosted in the company's Investors website; no other materials were mentioned.